Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Randomized, Double-blind, Placebo-controlled, Dose-escalation Phase 1 Clinical Tiral in Healthy Male Volunteers
Sponsor: Daewoong Pharmaceutical Co. LTD.
Summary
The safety and tolerability of single and multiple administration of DWP212525
Official title: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose, Dose-escalation Phase 1 Clinical Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP212525 in Healthy Male Volunteers
Key Details
Gender
MALE
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
76
Start Date
2024-12-10
Completion Date
2026-06-30
Last Updated
2024-12-18
Healthy Volunteers
Yes
Conditions
Interventions
DWP212525 10mg
DWP212525 10mg
DWP212525 30mg
DWP212525 30mg
DWP212525 50mg
DWP212525 50mg
DWP212525 100mg
DWP212525 100mg
DWP212525 200mg
DWP212525 200mg
DWP212525 400mg
DWP212525 400mg
DWP212525 placebo
DWP212525 placebo
Locations (1)
Seoul National University Hospital
Seoul, South Korea